info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Neuromodulation Devices Market Share, Growth and Insights By Type (Internal, External), Application (SCS, DBS, VNS, SNS, GES, TENS, TMS), Biomaterial (Metallic, Polymeric, Ceramic), End-User (Hospitals, Clinics, Homecare) โ€“ Forecast Till 2032


ID: MRFR/MED/0829-HCR | 115 Pages | Author: Kinjoll Dey| November 2024

Market Segmentation


Neuromodulation Devices Type Outlook (USD Billion, 2018-2032)




  • Internal




  • External




Neuromodulation Devices Application Outlook (USD Billion, 2018-2032)




  • SCS




  • DBS




  • VNS




  • SNS




  • GES




  • TENS




  • TMS




Neuromodulation Devices Biomaterial Outlook (USD Billion, 2018-2032)




  • Metallic




  • Polymeric




  • Ceramic




Neuromodulation Devices End-User Outlook (USD Billion, 2018-2032)




  • Hospitals




  • Clinics




  • Homecare




Neuromodulation Devices Regional Outlook (USD Billion, 2018-2032)




  • North AmericaOutlook (USD Billion, 2018-2032)




    • North America Neuromodulation Devices by Type




      • Internal




      • External






    • North America Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • North America Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • North America Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • US Outlook (USD Billion, 2018-2032)




    • US Neuromodulation Devices by Type




      • Internal




      • External






    • US Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • US Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • US Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Neuromodulation Devices by Type




      • Internal




      • External






    • CANADA Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • CANADA Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • CANADA Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Neuromodulation Devices by Type




      • Internal




      • External






    • Europe Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Europe Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Europe Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Neuromodulation Devices by Type




      • Internal




      • External






    • Germany Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Germany Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Germany Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • France Outlook (USD Billion, 2018-2032)




    • France Neuromodulation Devices by Type




      • Internal




      • External






    • France Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • France Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • France Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • UK Outlook (USD Billion, 2018-2032)




    • UK Neuromodulation Devices by Type




      • Internal




      • External






    • UK Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • UK Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • UK Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Neuromodulation Devices by Type




      • Internal




      • External






    • ITALY Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • ITALY Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • ITALY Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Neuromodulation Devices by Type




      • Internal




      • External






    • Spain Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Spain Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Spain Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Neuromodulation Devices by Type




      • Internal




      • External






    • REST OF EUROPE Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • REST OF EUROPE Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • REST OF EUROPE Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Neuromodulation Devices by Type




      • Internal




      • External






    • Asia-Pacific Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Asia-Pacific Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Asia-Pacific Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • China Outlook (USD Billion, 2018-2032)




    • China Neuromodulation Devices by Type




      • Internal




      • External






    • China Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • China Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • China Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Neuromodulation Devices by Type




      • Internal




      • External






    • Japan Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Japan Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Japan Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • India Outlook (USD Billion, 2018-2032)




    • India Neuromodulation Devices by Type




      • Internal




      • External






    • India Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • India Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • India Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Neuromodulation Devices by Type




      • Internal




      • External






    • Australia Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Australia Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Australia Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Neuromodulation Devices by Type




      • Internal




      • External






    • Rest of Asia-Pacific Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Rest of Asia-Pacific Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Rest of Asia-Pacific Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Neuromodulation Devices by Type




      • Internal




      • External






    • Rest of the World Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Rest of the World Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Rest of the World Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Neuromodulation Devices by Type




      • Internal




      • External






    • Middle East Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Middle East Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Middle East Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Neuromodulation Devices by Type




      • Internal




      • External






    • Africa Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Africa Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Africa Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Neuromodulation Devices by Type




      • Internal




      • External






    • Latin America Neuromodulation Devices by Application




      • SCS




      • DBS




      • VNS




      • SNS




      • GES




      • TENS




      • TMS






    • Latin America Neuromodulation Devices by Biomaterial




      • Metallic




      • Polymeric




      • Ceramic






    • Latin America Neuromodulation Devices by End-User




      • Hospitals




      • Clinics




      • Homecare







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porterโ€™s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Neuromodulation Devices Market, by Type

6.1 Introduction

6.2 Internal Neuromodulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

6.2.1 Spinal Cord Stimulation (SCS)

6.2.2 Deep Brain Stimulation (DBS)

6.2.3 Vagus Nerve Stimulation (VNS)

6.2.4 Sacral Nerve Stimulation (SNS)

6.2.5 Gastric Electrical Stimulation (GES)

6.3 External Neuromodulation (Non-Invasive)

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

6.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)

6.3.2 Transcranial Magnetic Stimulation (TMS)

6.3.3 Respiratory Electrical Stimulation (RES)

7. Global Neuromodulation Devices Market for Type by Application

7.1 Introduction

7.2 Spinal Cord Stimulation (SCS)

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.2.1 Chronic Pain Management

7.2.2 Failed Back Syndrome (FBSS)

7.2.3 Ischemia

7.3 Deep Brain Stimulation (DBS)

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.3.1 Parkinsonโ€™s Disease

7.3.2 Tremor

7.3.3 Depression

7.3.4 Other

7.4 Sacral Nerve Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.4.1 Urine Incontinence

7.4.2 Fecal Incontinence

7.5 Vagus Nerve Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.5.1 Epilepsy

7.5.2 Other

7.6 Gastric Electrical Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.6.1 Gastroparesis

7.6.2 Obesity

7.7 Transcutaneous Electrical Nerve Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.7.1 Treatment-Resistant Depression

7.7.2 Other

7.8 Repetitive Transcranial Magnetic Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.8.1 Depression

7.8.2 Migraine Headache

7.9 Respiratory Electrical Stimulation

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

7.9.1 Spinal Cord Injury

7.9.2 Others

8. Global Neuromodulation Devices Market, by Biomaterial

8.1 Introduction

8.2 Metallic Biomaterials

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

8.3 Polymeric Biomaterials

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

8.4 Ceramic Biomaterials

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

9. Global Neuromodulation Devices Market, by End-User

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

9.3 Clinics

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

9.4 Home healthcare

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

9.4 Others

Market Estimates & Forecast, 2020-2027

Market Estimates & Forecast, by Region/Country, 2020-2027

10 Global Neuromodulation Devices Market, by Region

10.1 Introduction

10.2 Americas

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.2.1 North America

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.2.1.1 U.S.

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.2.1.2 Canada

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.2.2 South America

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3 Europe

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1 Western Europe

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.1 Germany

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.2 France

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.3 U.K.

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.4 Italy

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.5 Spain

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.1.6 Rest of Western Europe

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.3.2 Eastern Europe

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4 Asia Pacific

Market Estimates & Forecast, by Country, 2020-2027

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.1 Japan

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.2 China

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.3 India

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.4 Australia

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.5 Republic of Korea

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.4.6 Rest of Asia Pacific

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.5 The Middle East & Africa

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.5.1 Middle East

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

10.5.2 Africa

Market Estimates & Forecast, by Type, 2020-2027

Market Estimates & Forecast, by Application, 2020-2027

Market Estimates & Forecast, by Biomaterial, 2020-2027

Market Estimates & Forecast, by End-User, 2020-2027

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Neurometrix, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 St. Jude Medical, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Synapse Biomedical, Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Nevro Corporation

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Neurosigma, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Medtronic Plc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Neuropace, Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Boston Scientific Corporation

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Cyberonics, Inc.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Biocontrol Medical

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Neuronetics, Inc.

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Aleva Neurotherapeutics SA

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 EnteroMedics Inc.

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 Bioness Inc.

12.14.1 Overview

12.14.2 Product Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Others

13 Appendix

LIST OF TABLES

Table 1 Neuromodulation Devices Industry Synopsis, 2020-2027

Table 2 Global Neuromodulation Devices Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Neuromodulation Devices Market, by Region, 2020-2027, (USD Million)

Table 5 Global Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 5 Global Neuromodulation Devices Market, by Application, 2020-2027, (USD Million)

Table 6 Global Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 7 Global Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 8 North America Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 9 North America Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 9 North America Neuromodulation Devices Market, by Application, 2020-2027, (USD Million)

Table 10 North America Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 11 U.S. Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 12 U.S. Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 12 U.S. Neuromodulation Devices Market, by Application, 2020-2027, (USD Million)

Table 13 U.S. Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 14 Canada Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 14 Canada Neuromodulation Devices Market, by Application, 2020-2027, (USD Million)

Table 15 Canada Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 16 Canada Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 17 South America Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 18 South America Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 19 South America Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 20 Europe Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 21 Europe Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 22 Europe Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 23 Western Europe Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 24 Western Europe Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 25 Western Europe Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 26 Eastern Europe Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 27 Eastern Europe Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 28 Eastern Europe Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 29 Asia Pacific Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 30 Asia Pacific Neuromodulation Devices Market, by Biomaterial, 2020-2027, (USD Million)

Table 31 Asia Pacific Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

Table 32 Middle East & Africa Neuromodulation Devices Market, by Type, 2020-2027, (USD Million)

Table 33 Middle East & Africa Neuromodulation Devices Market, by Application, 2020-2027, (USD Million)

Table 34 Middle East & Africa Neuromodulation Devices Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Neuromodulation Devices Market

Figure 3 Segmentation Market Dynamics for Neuromodulation Devices Market

Figure 4 Global Neuromodulation Devices Market Share, by Type 2020

Figure 5 Global Neuromodulation Devices Market Share, by Application 2020

Figure 6 Global Neuromodulation Devices Market Share, by End-User, 2020

Figure 7 Global Neuromodulation Devices Market Share, by Region, 2020

Figure 8 North America Neuromodulation Devices Market Share, by Country, 2020

Figure 9 Europe Neuromodulation Devices Market Share, by Country, 2020

Figure 10 Asia Pacific Neuromodulation Devices Market Share, by Country, 2020

Figure 11 Middle East & Africa Neuromodulation Devices Market Share, by Country, 2020

Figure 12 Global Neuromodulation Devices Market: Company Share Analysis, 2020 (%)

Figure 13 Neurometrix, Inc.: Key Financials

Figure 14 Neurometrix, Inc.: Segmental Revenue

Figure 16 Neurometrix, Inc.: Geographical Revenue

Figure 17 Synapse Biomedical, Inc.. Key Financials

Figure 18 Synapse Biomedical, Inc.: Segmental Revenue

Figure 19 Synapse Biomedical, Inc.: Geographical Revenue

Figure 20 Neuronetics, Inc. : Key Financials

Figure 21 Neuronetics, Inc. : Segmental Revenue

Figure 22 Neuronetics, Inc. : Geographical Revenue

Figure 23 Nevro Corporation: Key Financials

Figure 24 Nevro Corporation: Segmental Revenue

Figure 25 Nevro Corporation: Geographical Revenue

Figure 26 Biocontrol Medical : Key Financials

Figure 27 Biocontrol Medical : Segmental Revenue

Figure 28 Biocontrol Medical. Geographical Revenue

Figure 29 St. Jude Medical, Inc.. Key Financials

Figure 30 St. Jude Medical, Inc.. Segmental Revenue

Figure 31 St. Jude Medical, Inc.. Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.